Cargando…
Aripiprazole and Acute Extrapyramidal Symptoms in Children and Adolescents: A Meta-Analysis
BACKGROUND: Both the US FDA and the European Medicines Agency (EMA) have approved aripiprazole for use in adolescents for specific indications. Given the assumed favorable side-effect profile of aripiprazole, its use in children and adolescents has increased for both official and off-label indicatio...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4996892/ https://www.ncbi.nlm.nih.gov/pubmed/27395403 http://dx.doi.org/10.1007/s40263-016-0367-y |